{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:43:33Z","timestamp":1790279013889,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["ISR 56668477"],"award-info":[{"award-number":["ISR 56668477"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s40618-022-01740-7","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T15:05:34Z","timestamp":1641999934000},"page":"1045-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Direct effects of octreotide on osteoblast cell proliferation and function"],"prefix":"10.1007","volume":"45","author":[{"given":"E.","family":"Vitali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Palagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Schiavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sobacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"1740_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EJE-07-0562","volume":"158","author":"GF Taboada","year":"2008","unstructured":"Taboada GF, Luque RM, Neto LV et al (2008) Quantitative analysis of somatostatin receptor subtypes (1\u20135) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR. Eur J Endocrinol 158:295\u2013303. https:\/\/doi.org\/10.1530\/EJE-07-0562","journal-title":"Eur J Endocrinol"},{"key":"1740_CR2","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1097\/01.pas.0000174013.14569.90","volume":"29","author":"M K\u00f6rner","year":"2005","unstructured":"K\u00f6rner M, Eltschinger V, Waser B et al (2005) Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography. Am J Surg Pathol\u00a029:1642\u20131651.\u00a0https:\/\/doi.org\/10.1097\/01.pas.0000174013.14569.90","journal-title":"Am J Surg Pathol"},{"key":"1740_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11102-007-0062-6","volume":"11","author":"L De Marinis","year":"2008","unstructured":"De Marinis L, Bianchi A, Mazziotti G et al (2008) The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. Pituitary 11:13\u201320. https:\/\/doi.org\/10.1007\/s11102-007-0062-6","journal-title":"Pituitary"},{"key":"1740_CR4","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1210\/jc.2008-2332","volume":"94","author":"G Mazziotti","year":"2009","unstructured":"Mazziotti G, Floriani I, Bonadonna S et al (2009) Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J Clin Endocrinol Metab 94:1500\u20131508. https:\/\/doi.org\/10.1210\/jc.2008-2332","journal-title":"J Clin Endocrinol Metab"},{"key":"1740_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535\u2013559. https:\/\/doi.org\/10.1210\/er.2007-0036","journal-title":"Endocr Rev"},{"key":"1740_CR6","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/EJE-19-0184","volume":"181","author":"G Mazziotti","year":"2019","unstructured":"Mazziotti G, Lania AGA, Canalis E (2019) Bone disorders associated with acromegaly: mechanisms and treatment. Eur J Endocrinol 181:R45\u2013R56. https:\/\/doi.org\/10.1530\/EJE-19-0184","journal-title":"Eur J Endocrinol"},{"key":"1740_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1159\/000511811","volume":"111","author":"M Cellini","year":"2021","unstructured":"Cellini M, Biamonte E, Mazza M et al (2021) Vertebral fractures associated with spinal sagittal imbalance and quality of life in acromegaly: a radiographic study with EOS 2D\/3D technology. Neuroendocrinology 111:775\u2013785.\u00a0https:\/\/doi.org\/10.1159\/000511811","journal-title":"Neuroendocrinology"},{"key":"1740_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1530\/EJE-17-0772","volume":"178","author":"Z Belaya","year":"2018","unstructured":"Belaya Z, Grebennikova T, Melnichenko G et al (2018) Effects of active acromegaly on bone mRNA and microRNA expression patterns. Eur J Endocrinol 178:353\u2013364. https:\/\/doi.org\/10.1530\/EJE-17-0772","journal-title":"Eur J Endocrinol"},{"key":"1740_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11102-017-0847-1","volume":"21","author":"LD Carbonare","year":"2018","unstructured":"Dalle Carbonare L, Micheletti V, Cosaro E et al (2018) Bone histomorphometry in acromegaly patients with fragility vertebral fractures. Pituitary 21:56\u201364. https:\/\/doi.org\/10.1007\/s11102-017-0847-1","journal-title":"Pituitary"},{"key":"1740_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/ERC-17-0523","volume":"25","author":"MT Valenti","year":"2018","unstructured":"Valenti MT, Mottes M, Cheri S et al (2018) Runx2 overexpression compromises bone quality in acromegalic patients. Endocr Relat Cancer 25:269\u2013277. https:\/\/doi.org\/10.1530\/ERC-17-0523","journal-title":"Endocr Relat Cancer"},{"key":"1740_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz054","volume":"105","author":"S Chiloiro","year":"2020","unstructured":"Chiloiro S, Giampietro A, Frara S et al (2020) Effects of pegvisomant and pasireotide LAR on vertebral fractures in acromegaly resistant to first-generation SRLs. J Clin Endocrinol Metab\u00a0105:dgz054.\u00a0https:\/\/doi.org\/10.1210\/clinem\/dgz054","journal-title":"J Clin Endocrinol Metab"},{"key":"1740_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000508633","volume":"111","author":"M Cives","year":"2021","unstructured":"Cives M, Pell\u00e8 E, Rinzivillo M et al (2021) Bone metastases in neuroendocrine tumors: molecular pathogenesis and implications in clinical practice. Neuroendocrinology 111:207\u2013216. https:\/\/doi.org\/10.1159\/000508633","journal-title":"Neuroendocrinology"},{"key":"1740_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1677\/erc.1.01191","volume":"13","author":"E Ferrante","year":"2006","unstructured":"Ferrante E, Pellegrini C, Bondioni S et al (2006) Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2. Endocr Relat Cancer 13:955\u2013962. https:\/\/doi.org\/10.1677\/erc.1.01191","journal-title":"Endocr Relat Cancer"},{"key":"1740_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110803","volume":"509","author":"E Vitali","year":"2020","unstructured":"Vitali E, Boemi I, Piccini S et al (2020) A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells. Mol Cell Endocrinol 509:110803. https:\/\/doi.org\/10.1016\/j.mce.2020.110803","journal-title":"Mol Cell Endocrinol"},{"key":"1740_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1042\/bj2650039","volume":"265","author":"C Bruns","year":"1990","unstructured":"Bruns C, Dietl MM, Palacios JM, Pless J (1990) Identification and characterization of somatostatin receptors in neonatal rat long bones. Biochem J 265:39\u201344. https:\/\/doi.org\/10.1042\/bj2650039","journal-title":"Biochem J"},{"key":"1740_CR16","doi-asserted-by":"publisher","first-page":"R551","DOI":"10.1530\/ERC-16-0151","volume":"23","author":"K \u00d6berg","year":"2016","unstructured":"\u00d6berg K, Lamberts SWJ (2016) Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future. Endocr Relat Cancer 23:R551\u2013R566. https:\/\/doi.org\/10.1530\/ERC-16-0151","journal-title":"Endocr Relat Cancer"},{"key":"1740_CR17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/jbmr.3829","volume":"34","author":"C Menale","year":"2019","unstructured":"Menale C, Robinson LJ, Palagano E et al (2019) Absence of dipeptidyl peptidase 3 increases oxidative stress and causes bone loss. J Bone Miner Res 34:2133\u20132148. https:\/\/doi.org\/10.1002\/jbmr.3829","journal-title":"J Bone Miner Res"},{"key":"1740_CR18","doi-asserted-by":"publisher","first-page":"9193","DOI":"10.1158\/0008-5472.CAN-04-1847","volume":"64","author":"AG Lania","year":"2004","unstructured":"Lania AG, Mantovani G, Ferrero S et al (2004) Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase A regulatory subunit 1A protein. Cancer Res 64:9193\u20139198. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1847","journal-title":"Cancer Res"},{"key":"1740_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03701-z","author":"X Shen","year":"2021","unstructured":"Shen X, Wu C, Lei M et al (2021) Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-021-03701-z","journal-title":"Cell Death Dis"},{"key":"1740_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ab.2004.02.002","volume":"329","author":"CA Gregory","year":"2004","unstructured":"Gregory CA, Gunn WG, Peister A, Prockop DJ (2004) An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329:77\u201384. https:\/\/doi.org\/10.1016\/j.ab.2004.02.002","journal-title":"Anal Biochem"},{"key":"1740_CR21","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.2741\/2296","volume":"12","author":"W Huang","year":"2007","unstructured":"Huang W, Yang S, Shao J, Li YP (2007) Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12:3068\u20133092.\u00a0https:\/\/doi.org\/10.2741\/2296","journal-title":"Front Biosci"},{"key":"1740_CR22","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1002\/jcp.29575","volume":"235","author":"ML Schiavone","year":"2020","unstructured":"Schiavone ML, Millucci L, Bernardini G et al (2020) Homogentisic acid affects human osteoblastic functionality by oxidative stress and alteration of the Wnt\/\u03b2-catenin signaling pathway. J Cell Physiol 235:6808\u20136816. https:\/\/doi.org\/10.1002\/jcp.29575","journal-title":"J Cell Physiol"},{"key":"1740_CR23","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1517\/14656566.2013.847090","volume":"14","author":"A Giustina","year":"2013","unstructured":"Giustina A, Karamouzis I, Patelli I, Mazziotti G (2013) Octreotide for acromegaly treatment: a reappraisal. Expert Opin Pharmacother 14:2433\u20132447. https:\/\/doi.org\/10.1517\/14656566.2013.847090","journal-title":"Expert Opin Pharmacother"},{"key":"1740_CR24","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:3933\u20133951.\u00a0https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"key":"1740_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.17.S4.1","volume":"17","author":"L Katznelson","year":"2011","unstructured":"Katznelson L, Atkinson JLD, Cook DM et al (2011) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly\u20132011 update. Endocr Pract 17:1\u201344. https:\/\/doi.org\/10.4158\/EP.17.S4.1","journal-title":"Endocr Pract"},{"key":"1740_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/MPA.0b013e31828e34a4","volume":"42","author":"PL Kunz","year":"2013","unstructured":"Kunz PL, Reidy-Lagunes D, Anthony LB et al (2013) Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas 42:557\u2013577. https:\/\/doi.org\/10.1097\/MPA.0b013e31828e34a4","journal-title":"Pancreas"},{"key":"1740_CR27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nrd1255","volume":"2","author":"G Weckbecker","year":"2003","unstructured":"Weckbecker G, Lewis I, Albert R et al (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2:999\u20131017.\u00a0https:\/\/doi.org\/10.1038\/nrd1255","journal-title":"Nat Rev Drug Discov"},{"key":"1740_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/ERC-15-0358","volume":"23","author":"E Vitali","year":"2016","unstructured":"Vitali E, Cambiaghi V, Zerbi A et al (2016) Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours. Endocr Relat Cancer 23:181\u2013190. https:\/\/doi.org\/10.1530\/ERC-15-0358","journal-title":"Endocr Relat Cancer"},{"key":"1740_CR29","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1210\/endo.136.10.7664634","volume":"136","author":"NW Cheung","year":"1995","unstructured":"Cheung NW, Boyages SC (1995) Somatostatin-14 and its analog octreotide exert a cytostatic effect on gh3 rat pituitary tumor cell proliferation via a transient g0\/g1 cell cycle block. Endocrinology 136:4174\u20134181. https:\/\/doi.org\/10.1210\/endo.136.10.7664634","journal-title":"Endocrinology"},{"key":"1740_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mce.2018.12.022","volume":"483","author":"D Treppiedi","year":"2019","unstructured":"Treppiedi D, Giardino E, Catalano R et al (2019) Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1\/2 activity. Mol Cell Endocrinol 483:31\u201338. https:\/\/doi.org\/10.1016\/j.mce.2018.12.022","journal-title":"Mol Cell Endocrinol"},{"key":"1740_CR31","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/0008-5472.CAN-09-2951","volume":"70","author":"V Cerovac","year":"2010","unstructured":"Cerovac V, Monteserin-Garcia J, Rubinfeld H et al (2010) The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells. Cancer Res 70:666\u2013674. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2951","journal-title":"Cancer Res"},{"key":"1740_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1210\/mend.13.1.0220","volume":"13","author":"K Sharma","year":"1999","unstructured":"Sharma K, Patel YC, Srikant CB (1999) C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest. Mol Endocrinol 13:82\u201390. https:\/\/doi.org\/10.1210\/mend.13.1.0220","journal-title":"Mol Endocrinol"},{"key":"1740_CR33","doi-asserted-by":"publisher","first-page":"15186","DOI":"10.1074\/jbc.274.21.15186","volume":"274","author":"P Pag\u00e8s","year":"1999","unstructured":"Pag\u00e8s P, Benali N, Saint-Laurent N et al (1999) sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1. J Biol Chem 274:15186\u201315193. https:\/\/doi.org\/10.1074\/jbc.274.21.15186","journal-title":"J Biol Chem"},{"key":"1740_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00437","volume":"10","author":"P Maffei","year":"2019","unstructured":"Maffei P, Dassie F, Wennberg A et al (2019) The endothelium in acromegaly. Front Endocrinol (Lausanne). 10:437.\u00a0https:\/\/doi.org\/10.3389\/fendo.2019.00437","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1740_CR35","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCRESAHA.112.300695","volume":"112","author":"M Duran-Prado","year":"2013","unstructured":"Duran-Prado M, Morell M, Delgado-Maroto V et al (2013) Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation. Circ Res.\u00a0112:1444\u20131455.\u00a0https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.300695","journal-title":"Circ Res"},{"key":"1740_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.regpep.2009.09.005","volume":"159","author":"Y Liu","year":"2010","unstructured":"Liu Y, Zhou YB, Zhang GG et al (2010) Cortistatin attenuates vascular calcification in rats. Regul Pept. 159:35\u201343.\u00a0https:\/\/doi.org\/10.1016\/j.regpep.2009.09.005","journal-title":"Regul Pept"},{"key":"1740_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MPA.0000000000000267","volume":"44","author":"J Kavecansky","year":"2015","unstructured":"Kavecansky J, Wei L, Caronia L et al (2015) Bone metastases in well-to-moderately differentiated neuroendocrine tumors: a single institutional review from the Ohio state university medical center. Pancreas 44:198\u2013203.\u00a0https:\/\/doi.org\/10.1097\/MPA.0000000000000267","journal-title":"Pancreas"},{"key":"1740_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000438902","volume":"103","author":"M Cives","year":"2016","unstructured":"Cives M, Rizzo F, Simone V et al (2016) Reviewing the osteotropism in neuroendocrine tumors: the role of epithelial-mesenchymal transition. Neuroendocrinology\u00a0103:321\u2013334.\u00a0https:\/\/doi.org\/10.1159\/000438902","journal-title":"Neuroendocrinology"},{"key":"1740_CR39","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3390\/ijms17101674","volume":"17","author":"C Kan","year":"2016","unstructured":"Kan C, Vargas G, Le Pape F, Cl\u00e9zardin P (2016) Cancer cell colonisation in the bone microenvironment. Int J Mol Sci 17:1674. https:\/\/doi.org\/10.3390\/ijms17101674","journal-title":"Int J Mol Sci"},{"key":"1740_CR40","first-page":"309","volume":"21","author":"H Iguchi","year":"2002","unstructured":"Iguchi H, Yokota M, Fukutomi M et al (2002) A possible role of VEGF in osteolytic bone metastasis of hepatocellular Carcinoma. J Exp Clin Cancer Res 21:309\u2013313","journal-title":"J Exp Clin Cancer Res"},{"key":"1740_CR41","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Bianchi A, Porcelli T et al (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98:3402\u20133410. https:\/\/doi.org\/10.1210\/jc.2013-1460","journal-title":"J Clin Endocrinol Metab"},{"key":"1740_CR42","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1210\/jc.2013-2695","volume":"98","author":"KMJA Claessen","year":"2013","unstructured":"Claessen KMJA, Kroon HM, Pereira AM et al (2013) Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J Clin Endocrinol Metab 98:4808\u20134815.\u00a0https:\/\/doi.org\/10.1210\/jc.2013-2695","journal-title":"J Clin Endocrinol Metab"},{"key":"1740_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/EJE-16-0808","volume":"176","author":"F Malgo","year":"2017","unstructured":"Malgo F, Hamdy NAT, Rabelink TJ et al (2017) Bone material strength index as measured by impact microindentation is altered in patients with acromegaly. Eur J Endocrinol 176:339\u2013347. https:\/\/doi.org\/10.1530\/EJE-16-0808","journal-title":"Eur J Endocrinol"},{"key":"1740_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/EJE-18-0881","volume":"180","author":"M Ku\u017ema","year":"2019","unstructured":"Ku\u017ema M, Va\u0148uga P, S\u00e1gova I et al (2019) Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study. Eur J Endocrinol 180:201\u2013211. https:\/\/doi.org\/10.1530\/EJE-18-0881","journal-title":"Eur J Endocrinol"},{"key":"1740_CR45","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11102-018-0873-7","volume":"21","author":"S Chiloiro","year":"2018","unstructured":"Chiloiro S, Mazziotti G, Giampietro A et al (2018) Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. Pituitary 21:302\u2013308. https:\/\/doi.org\/10.1007\/s11102-018-0873-7","journal-title":"Pituitary"},{"key":"1740_CR46","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2018-00005","volume":"39","author":"G Mazziotti","year":"2018","unstructured":"Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and bone. Endocr Rev 39:440\u2013488. https:\/\/doi.org\/10.1210\/er.2018-00005","journal-title":"Endocr Rev"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01740-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01740-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01740-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T09:22:22Z","timestamp":1649582542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01740-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01740-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]},"assertion":[{"value":"25 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there is no conflict of interests in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal procedures were performed in accordance with the ethical rules of the Institutional Animal Care and Use Committee of Humanitas Research Hospital in the framework of the protocol n.876\/2017-PR. The murine primary cells generated in this circumstance were used for the present study in accordance with the Reduction guideline (3Rs) which is internationally recognized and encouraged.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This work has been approved for publication by all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}